95 related articles for article (PubMed ID: 7498466)
21. Novel Cu(II)-RGD-octapeptides: Synthesis, coordination mode, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and correlation of sequence with nano-structure.
Li N; Kang G; Gui L; Zhao M; Wang W; Zhang J; Yue YF; Peng S
Nanomedicine; 2011 Aug; 7(4):403-9. PubMed ID: 21272663
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets.
Ruggeri ZM; Houghten RA; Russell SR; Zimmerman TS
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5708-12. PubMed ID: 3016716
[TBL] [Abstract][Full Text] [Related]
23. Proline brackets and identification of potential functional sites in proteins: toxins to therapeutics.
Kini RM
Toxicon; 1998 Nov; 36(11):1659-70. PubMed ID: 9792183
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and activity of a cyclo-heptapeptide containing Lys-Gly-Asp-sequence as a novel anti-platelet agent.
Jing J
Bioorg Khim; 2013; 39(5):547-51. PubMed ID: 25702411
[TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
[TBL] [Abstract][Full Text] [Related]
26. [A new thrombocyte aggregation-inhibiting and fibrinolysis-promoting synthetic molecule: RGDF (Arg-Gly-Asp-Phe) coupled with the carboxyterminal antiplasmin peptide].
Udrardy M; Schwartzott D; Jackson K; McKee PA
Orv Hetil; 1995 Jan; 136(3):129-33. PubMed ID: 7870410
[TBL] [Abstract][Full Text] [Related]
27. RGDFAP: platelet aggregation inhibitory and profibrinolytic hybrid peptide (RGDF coupled with the carboxy terminal part of alpha 2-antiplasmin) enhances plasminogen binding to platelets.
Udvardy M; Schwartzott D; Jackson K; Posan E; Rak K; McKee PA
Blood Coagul Fibrinolysis; 1995 Jul; 6(5):481-5. PubMed ID: 8589217
[TBL] [Abstract][Full Text] [Related]
28. Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.
Puri RN; Matsueda R; Umeyama H; Bradford HN; Colman RW
Eur J Biochem; 1993 May; 214(1):233-41. PubMed ID: 8389701
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the role of proline residues flanking the RGD motif of dendroaspin, an inhibitior of platelet aggregation and cell adhesion.
Lu X; Sun Y; Shang D; Wattam B; Egglezou S; Hughes T; Hyde E; Scully M; Kakkar V
Biochem J; 2001 May; 355(Pt 3):633-8. PubMed ID: 11311124
[TBL] [Abstract][Full Text] [Related]
30. Essential groups in synthetic agonist peptides for activation of the platelet thrombin receptor.
Chao BH; Kalkunte S; Maraganore JM; Stone SR
Biochemistry; 1992 Jul; 31(27):6175-8. PubMed ID: 1320929
[TBL] [Abstract][Full Text] [Related]
31. Identification of the disulfide bond pattern in albolabrin, an RGD-containing peptide from the venom of Trimeresurus albolabris: significance for the expression of platelet aggregation inhibitory activity.
Calvete JJ; Schäfer W; Soszka T; Lu WQ; Cook JJ; Jameson BA; Niewiarowski S
Biochemistry; 1991 May; 30(21):5225-9. PubMed ID: 2036389
[TBL] [Abstract][Full Text] [Related]
32. Thrombus imaging using technetium-99m-labeled high-potency GPIIb/IIIa receptor antagonists. Chemistry and initial biological studies.
Pearson DA; Lister-James ; McBride WJ; Wilson DM; Martel LJ; Civitello ER; Dean RT
J Med Chem; 1996 Mar; 39(7):1372-82. PubMed ID: 8691467
[TBL] [Abstract][Full Text] [Related]
33. The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by saos-2 human osteosarcoma cells.
Chiang HS; Yang RS; Huang TF
Br J Cancer; 1995 Feb; 71(2):265-70. PubMed ID: 7841039
[TBL] [Abstract][Full Text] [Related]
34. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
[TBL] [Abstract][Full Text] [Related]
35. Novel non-peptide fibrinogen receptor antagonists. 1. Synthesis and glycoprotein IIb-IIIa antagonistic activities of 1,3,4-trisubstituted 2-oxopiperazine derivatives incorporating side-chain functions of the RGDF peptide.
Sugihara H; Fukushi H; Miyawaki T; Imai Y; Terashita Z; Kawamura M; Fujisawa Y; Kita S
J Med Chem; 1998 Feb; 41(4):489-502. PubMed ID: 9484499
[TBL] [Abstract][Full Text] [Related]
36. Peptidyl antithrombogenic agents for extracorporeal blood circulation.
Ito S; Matsuda T; Takemoto Y; Yamamoto K; Kishimoto T; Maekawa M
Int J Artif Organs; 1992 Dec; 15(12):737-45. PubMed ID: 1493949
[TBL] [Abstract][Full Text] [Related]
37. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
[TBL] [Abstract][Full Text] [Related]
38. Structure-activity studies of the s-echistatin inhibition of bone resorption.
Sato M; Garsky V; Majeska RJ; Einhorn TA; Murray J; Tashjian AH; Gould RJ
J Bone Miner Res; 1994 Sep; 9(9):1441-9. PubMed ID: 7817829
[TBL] [Abstract][Full Text] [Related]
39. A modified Arg-Asp-Val (RDV) peptide derived during the synthesis of Arg-Glu-Asp-Val (REDV), a tetrapeptide derived from an alternatively spliced site in fibronectin, inhibits the binding of fibrinogen, fibronectin, von Willebrand factor and vitronectin to activated platelets.
Chen CS; Papayannopoulos IA; Timmons S; Chou SH; Thiagarajan P
Biochim Biophys Acta; 1991 Oct; 1075(3):237-47. PubMed ID: 1720019
[TBL] [Abstract][Full Text] [Related]
40. [Hydrochloride of the peptide Boc-Gly-Pro-Arg-OMe--a selective inhibitor of thrombin- and epinephrine-induced platelet aggregation].
Evstigneeva RP; Kubatiev AA; Tkachenko SB; Zheltukhina GA
Dokl Akad Nauk; 1994 Aug; 337(5):680-2. PubMed ID: 7987230
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
